Octaplex
Octaplex is a pharmaceutical drug with 2 clinical trials. Historical success rate of 66.7%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
2 source entries across 2 studies. This list may not include all unresolved or historical entries.
- OctaplexRegistry intervention
Linked study entry; product equivalence not established
View study and source - OctaplexRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
0
trials recruiting
2
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Trials (2)
Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor
Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery
All 2 trials loaded
Drug Details
- Intervention Type
- Drug
- Total Trials
- 2